SRSarah K. Rapoport

Sarah K. Rapoport

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sarah K. Rapoport has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Rare Complications Of A Popular Procedure: A Multi-institutional Case Series of Superior Laryngeal Nerve Block (SLN) Complications

    by Stefanie M. Miller, Abdullah M. Alanazi, Hayley L. Born, David Garber, Sarah K. Rapoport, Manish A. Shaha, Elizabeth A. Shuman, Andrew P. Stein, Andrew G. Tritter, Zao Mike Yang, et al.

  • Evaluating Trends in Medicare Reimbursements Between Male and Female Otolaryngologists From 2013 to 2018

    by Corinne A. Pittman, Holly D. Shan, Varsha Harish, Sarah K. Rapoport

    Objective: Gender‐based pay disparities exist in otolaryngology. Determining whether such patterns have been consistently present could help expose whether, and to what extent, gender‐based inequalities exist within our field.Study Design: Retrospective, cross‐sectional analysis of publicly available Centers for Medicare and Medicaid Services (CMS) data for otolaryngologists from 2013 to 2018.Setting: A database study.Methods: CMS databases were used to evaluate whether gender differences exist within clinical productivity and reimbursement patterns among otolaryngologists over time, and if so, what those trends have been. Outcomes included the number of unique billing codes and charges submitted per physician (clinical productivity) and physician reimbursements. Results were controlled for geography, levels of clinical productivity, and gender.Results: Male otolaryngologists consistently submitted more charges for reimbursement (median [interquartile range, IQR], 291,539 [154,380‐503,932] vs 196,029 [94,849‐337,224]) and a greater number of unique billing codes (median [IQR], 52.0 [34.0‐72.0] vs 41.0 [27.0‐59.0]) than female otolaryngologists. Male otolaryngologists received greater reimbursements than female otolaryngologists (median [IQR], $114,390 [$61,732‐$184,209] vs $72,679 [$34,855‐$122,473]). Contrast ratios of estimated marginal means for reimbursements between male and female otolaryngologists demonstrated that 75% to 81% (P < .0001) of the estimated payment for physician services were received by male otolaryngologists.Conclusion: There appears to be a consistent, general trend that the female gender is associated with decreased clinical productivity and lower CMS payments among otolaryngologists. These disparities persist even among highly productive female otolaryngologists. To better address gender pay disparities within otolaryngology, billing patterns among female otolaryngologists should be more closely assessed to help optimize reimbursement patterns for equivalent services provided by male otolaryngologists.Level of Evidence: Level IV.


  • Surgical Concepts in Transgender Voice Change

    by Sarah K. Rapoport, Sarah K. Brown

  • Patient Satisfaction and Acoustic Changes in Trans Women after Gender Affirming Voice Training

    by Sarah K. Rapoport, Eleni A Varelas, Christopher Park, Sarah K. Brown, Leanne Goldberg, Mark S. Courey

    Objectives: Gains in pitch from gender affirming voice training (GVT) alone in trans women have historically been shown to decline after 1 year. Currently no standard exists for length and type of GVT that yields meaningful behavioral change and patient satisfaction with voice outcomes in trans women. This study aims to determine whether GVT alone leads to sustained pitch elevation and patient satisfaction in trans women.Methods: Retrospective review from 2016 to 2020 of trans women patients who underwent GVT alone for voice change. Charts were reviewed for acoustic analysis of pitch including sustained vowel fundamental frequency, speaking fundamental frequency, and quality of life data from the Trans Woman Voice Questionnaire at pre‐therapy, immediate post‐therapy, and extended post‐therapy time intervals.Results: A total of 157 patients presented to our Voice Center, of which 34 participated in the full course of GVT. Patients underwent an average of six sessions of GVT (range 5–7) over an average of 13.14 weeks (range 6–16). Average time between completing GVT and presenting for extended follow‐up was 11.37 months (range 6–31). Compared to initial presentation prior to therapy, at extended follow‐up after completing GVT average change in F0/a/, SF0, and TWVQ were 64.6 Hz, 31.3 Hz, and 32.45. No significant change was noted between immediate post‐therapy and extended post‐therapy acoustic measures. TWVQ demonstrated continued improvement between immediate post‐therapy and extended post‐therapy.Conclusions: In self‐selected patients who present for extended follow‐up, GVT alone can result in sustained pitch elevation and voice‐related quality life in trans women.Level of Evidence: 4 Laryngoscope, 133:2340–2345, 2023


  • Positive Predictive Value of Endoscopic Findings to Diagnose Vocal Fold Paresis

    by Sarah K. Rapoport, Usmaan Basharat, Diana N. Kirke, Mark S. Courey

    Objective: Laryngoscopy corresponding with laryngeal electromyography (LEMG) is essential in diagnosing vocal fold paresis. However, baseline asymmetry or other diseases oftentimes confound the exam, making diagnosis difficult. There is currently no agreed upon endoscopic criteria proven to reliably correlate with LEMG findings. We define a set of endoscopic findings termed “paresis triad” that, when present together, reliably correlate with LEMG. The paresis triad consists of (1) hypocontraction of the weak side of the larynx with increased ventricular show, (2) hypercontraction of the intact side with bulging of the false fold covering the ventricle, and (3) tilting of the interarytenoid cleft to the weak side.Methods: We performed a retrospective review of patients with laryngeal asymmetry on laryngoscopy. Patients were divided into two groups: those with consistent paresis triad findings across all pitches and intensities, and those without. All patients underwent LEMG by a neurolaryngologist blinded to the laryngoscopic findings. The endoscopies were then rereviewed in a blinded manner by a second laryngologist to assess inter‐ and intrarater reliability for identification of the triad.Results: Twelve patients met inclusion criteria (age 50 +/−15, 7F:5M). Nine had the paresis triad. Three had an inconsistent triad. All patients with the paresis triad had LEMG findings consistent with neurologic injury on the suspected side. All patients with inconsistent triad findings had normal LEMG.Conclusions: Our findings suggest the proposed laryngoscopic paresis triad may be useful objective criteria to diagnose paresis without the need for LEMG. Further prospective studies should examine a larger series of patients.Level of Evidence: 4 Laryngoscope, 133:1712–1716, 2023


  • 1‐Year Results of Combined Modified Wendler Glottoplasty with Voice Therapy in Transgender Women

    by Sarah K. Rapoport, Christopher Park, Eleni A Varelas, Joseph Chang, Sarah K. Brown, Eliezer Kinberg, Leanne Goldberg, Mark S. Courey

    Background: To date, 1‐year evaluation of pitch elevation in patients undergoing modified Wendler glottoplasty (WG) in combination with VT has not been assessed.Objectives: To determine whether 1‐year pitch elevation is sustained in patients who undergo modified WG in combination with VT for voice feminization.Methods: A retrospective review of patients who underwent WG in combination with voice therapy (VT) was performed from 2016 to 2020. Charts were reviewed for sustained vowel fundamental frequency (F0/a/), speaking fundamental frequency (SF0), and Trans Woman Voice Questionnaire (TWVQ) at preoperative, initial postoperative (3–6 months after surgery), and 12‐month postoperative visits.Results: Change in average F0/a/, SF0 and TWVQ was 50.25 Hz, 32.96 Hz, and 32.6 at 12‐months postoperatively compared to preoperative values. Initial and 12‐month postoperative SF0 were significantly higher than preoperative SF0 (Mann–Whitney U test p = 0.0042, p = 0.0010). There was no difference in initial postoperative and 12‐month postoperative SF0 (p = 0.50). TWVQ at 12 months was significantly lower than preoperative TWVQ (ANOVA p < 0.001, Tukey honestly significant difference HSD p < 0.05).Conclusions: Pitch elevation remains sustained at one year in patients undergoing modified WG in combination with VT. Modified Wendler glottoplasty combined with VT results in relatively long‐term improvements in voice‐related quality of life and is possibly a beneficial addition in the long‐term management of patients who desire voice feminization.Level of Evidence: 4 Laryngoscope, 133:615–620, 2023


  • Open Access

    Long‐term upper aerodigestive sequelae as a result of infection with COVID‐19

    by Annie E. Allisan‐Arrighi, Sarah K. Rapoport, Benjamin M. Laitman, Rohini Bahethi, Matthew Mori, Peak Woo, Eric Genden, Mark Courey, Diana N. Kirke

    Objectives: Respiratory, voice, and swallowing difficulties after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) may result secondary to upper airway disease from prolonged intubation or mechanisms related to the virus itself. We examined a cohort who presented with new laryngeal complaints following documented SARS‐CoV‐2 infection. We characterized their voice, airway, and/or swallowing symptoms and reviewed the clinical course of their complaints to understand how the natural history of these symptoms relates to COVID‐19 infections.Methods: Retrospective review of patients who presented to our department with upper aerodigestive complaints as sequelae of prior infection with, and management of, SARS‐CoV‐2.Results: Eighty‐one patients met the inclusion criteria. Median age was 54.23 years (±17.36). Most common presenting symptoms were dysphonia (n = 58, 71.6%), dysphagia/odynophagia (n = 16, 19.75%), and sore throat (n = 9, 11.11%). Thirty‐one patients (38.27%) presented after intubation. Mean length of intubation was 16.85 days (range 1–35). Eighteen patients underwent tracheostomy and were decannulated after an average of 70.69 days (range 23–160). Patients with history of intubation were significantly more likely than nonintubated patients to be diagnosed with a granuloma (8 vs. 0, respectively, p < .01). Fifty patients (61.73%) were treated for SARS‐CoV‐2 without requiring intubation and were significantly more likely to be diagnosed with muscle tension dysphonia (19 vs. 1, p < .01) and laryngopharyngeal reflux (18 vs. 1, p < .01).Conclusion: In patients with persistent dyspnea, dysphonia, or dysphagia after recovering from SARS‐CoV‐2, early otolaryngology consultation should be considered. Accurate diagnosis and prompt management of these common underlying etiologies may improve long‐term patient outcomes.Level of evidence: 4


  • Long-Term Voice Outcomes After Type I, Type II, or Type V Cordectomy

    by Eliezer Kinberg, Sarah K. Rapoport, Sarah Brown, Peak Woo

    Introduction: We compare long-term voice outcomes in patients treated with European Laryngeal Society (ELS) classification Type I, Type II, or Type V cordectomy. The aim is to understand the impact of Type V cordectomy on voice outcomes in relation to Type I and Type II cordectomy. Methods: A retrospective review of patients treated with Type I, Type II, or Type V cordectomy by a single surgeon over a 20-year period was performed. Voice Handicap Index-10 (VHI-10) scores, Cepstral Spectral Index of Dysphonia (CSID) measures from CAPE-V sentences, and two-rater GRBAS scores were analyzed. Results: Sixty-two patients were identified with a mean follow-up of 52 months. Of these, there were 43 Type I and 19 Type II cordectomies, including 8 in each group with Type V resections. Significant differences in all parameters were noted between the Type I (VHI 5.7, CSID 20.6, Grade 1.3) and the Type II cohorts (VHI 12.6, CSID 36.3, Grade 1.8) who did not undergo Type V cordectomy. Patients undergoing Type V cordectomy demonstrated voice outcomes (VHI 9.4, CSID 35.6, Grade 1.7) which fell between those of Type I and Type II cordectomies. Conclusions: Better long-term subjective, objective, and computer-analyzed voice outcomes are noted for patients undergoing Type I rather than Type II cordectomy. When Type V cordectomy is performed, voice outcomes are comparable to those of both Type I and Type II cordectomy, a surprising finding given the expectation of worsened dysphonia in longer resections. Further work is needed to explain this finding and define voice outcomes after Type V cordectomy.